Detalles de la búsqueda
1.
Survival impact of sequential chemotherapy following pembrolizumab for recurrent or metastatic head and neck squamous cell carcinoma.
Int J Clin Oncol;
2024 Mar 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-38555323
2.
Exploratory analysis of serum HER2 extracellular domain for HER2 positive gastric cancer treated with SOX plus trastuzumab.
Int J Clin Oncol;
2024 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-38589679
3.
Bevacizumab, Irinotecan, and Biweekly Trifluridine/Tipiracil for Metastatic Colorectal Cancer: MODURATE, a Phase Ib Study.
Oncologist;
28(11): e1108-e1113, 2023 Nov 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37284901
4.
Pattern of disease progression during third-line or later chemotherapy with nivolumab associated with poor prognosis in advanced gastric cancer: a multicenter retrospective study in Japan.
Gastric Cancer;
26(1): 132-144, 2023 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36316527
5.
Nivolumab versus irinotecan as third- or later-line treatment for advanced gastric cancer: a multi-center retrospective study.
Int J Clin Oncol;
28(6): 756-763, 2023 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-36943545
6.
Clinical outcomes of patients diagnosed with cancer of unknown primary or malignancy of undefined primary origin who were referred to a regional cancer center.
Int J Clin Oncol;
28(5): 644-653, 2023 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-36899286
7.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with high tumor mutational burden tumors.
Int J Clin Oncol;
28(8): 941-955, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37300720
8.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of immunotherapy in patients with DNA mismatch repair deficient (dMMR) tumors, third edition.
Int J Clin Oncol;
28(10): 1237-1258, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37599324
9.
Japanese Society of Medical Oncology/Japan Society of Clinical Oncology/Japanese Society of Pediatric Hematology/Oncology-led clinical recommendations on the diagnosis and use of tropomyosin receptor kinase inhibitors in adult and pediatric patients with neurotrophic receptor tyrosine kinase fusion-positive advanced solid tumors.
Int J Clin Oncol;
28(7): 827-840, 2023 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-37212982
10.
Effectiveness of taxanes following nivolumab in patients with advanced esophageal squamous cell carcinoma: a retrospective chart review of patients in ATTRACTION-3.
Esophagus;
20(2): 302-308, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36564602
11.
The impact of combined PD-L1 positive score on clinical response to nivolumab in patients with advanced esophageal squamous cell carcinoma.
Esophagus;
20(3): 524-532, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36595124
12.
Complete response to definitive chemoradiotherapy in unresectable locally advanced esophageal squamous cell carcinoma.
Esophagus;
20(3): 533-540, 2023 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-36750480
13.
Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol;
23(2): 234-247, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-35030335
14.
A retrospective 5-year survival analysis of surgically resected gastric cancer cases from the Japanese Gastric Cancer Association nationwide registry (2001-2013).
Gastric Cancer;
25(6): 1082-1093, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35790645
15.
Eosinophil prognostic scores for patients with head and neck squamous cell carcinoma treated with nivolumab.
Cancer Sci;
112(1): 339-346, 2021 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-33078505
16.
Long-Term Outcome of Patients with Locally Advanced Clinically Unresectable Esophageal Cancer Undergoing Conversion Surgery after Induction Chemotherapy with Docetaxel Plus Cisplatin and 5-Fluorouracil.
Ann Surg Oncol;
28(2): 712-721, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-32761331
17.
The interplay of KRAS mutational status with tumor laterality in non-metastatic colorectal cancer: An international, multi-institutional study in patients with known KRAS, BRAF, and MSI status.
J Surg Oncol;
123(4): 1005-1014, 2021 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-33368279
18.
Surgically treated gastric cancer in Japan: 2011 annual report of the national clinical database gastric cancer registry.
Gastric Cancer;
24(3): 545-566, 2021 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-33811588
19.
A triplet combination of FOLFOXIRI plus cetuximab as first-line treatment in RAS wild-type, metastatic colorectal cancer: a dose-escalation phase Ib study.
Int J Clin Oncol;
26(4): 701-707, 2021 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-33386556
20.
Clinical impact of weekly paclitaxel plus cetuximab is comparable to the EXTREME regimen for recurrent/metastatic head and neck squamous cell carcinoma.
Int J Clin Oncol;
26(7): 1188-1195, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-33821363